Sox-10 activators are a class of chemical compounds that selectively upregulate the activity of Sox-10, a transcription factor that is part of the SOX (SRY-related HMG-box) family of DNA-binding proteins. The Sox-10 protein is pivotal in the development and function of neural crest cells, which give rise to a diverse array of cell types, including melanocytes, peripheral neurons, and Schwann cells. Sox-10 binds to DNA at specific sequences and regulates the expression of genes that are essential for the survival, proliferation, differentiation, and migration of neural crest derivatives. The transcriptional activity of Sox-10 is subject to intricate regulation through post-translational modifications, promoter context, and interactions with other transcription factors and co-factors. Sox-10 activators typically increase the transcriptional activity of Sox-10, either by enhancing its DNA binding affinity, promoting its nuclear localization, or facilitating its interaction with other proteins that are involved in the transcriptional machinery.
Chemically, Sox-10 activators may encompass a variety of structures including small organic molecules, peptides, or natural products. These activators may operate through diverse mechanisms to exert their effects on Sox-10. Some may bind directly to Sox-10, inducing conformational changes that promote a more active form of the protein or facilitate its dimerization, which is often required for high-affinity DNA binding and functional activity. Others might indirectly activate Sox-10 by modulating signaling pathways that lead to the phosphorylation, sumoylation, or acetylation of the protein, thereby affecting its function.
SEE ALSO...
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Elevates cAMP levels, thus enhancing PKA activity which can lead to the activation of Sox-10. | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
Inhibits Notch signaling, thus indirectly elevating Sox-10 levels by removing Notch-mediated suppression. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
An HDAC inhibitor that promotes Sox-10 gene transcription via histone acetylation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $65.00 $267.00 | 257 | |
JNK inhibitor that removes MAPK-mediated suppression, indirectly activating Sox-10. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor that can indirectly enhance Sox-10 levels by disabling a counteracting pathway. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
ROCK inhibitor that indirectly upregulates Sox-10 through altering cytoskeleton dynamics and gene expression. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
TGF-beta inhibitor that can indirectly elevate Sox-10 levels by removing TGF-beta mediated suppression. | ||||||
IWR-1-endo | 1127442-82-3 | sc-295215 sc-295215A | 5 mg 10 mg | $82.00 $132.00 | 19 | |
Wnt pathway inhibitor that, when inhibited, can lead to Sox-10 activation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
ERK inhibitor that can remove ERK-mediated suppression of Sox-10. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
HDAC inhibitor that can increase Sox-10 transcription through histone acetylation. |